Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2016

Open Access 01-12-2016 | Study protocol

Morita therapy for depression and anxiety (Morita Trial): study protocol for a pilot randomised controlled trial

Authors: Holly Victoria Rose Sugg, David A. Richards, Julia Frost

Published in: Trials | Issue 1/2016

Login to get access

Abstract

Background

Morita Therapy, a psychological therapy for common mental health problems, is in sharp contrast to established western psychotherapeutic approaches in teaching that undesired symptoms are natural features of human emotion rather than something to control or eliminate. The approach is widely practiced in Japan, but untested and little known in the UK. A clinical trial of Morita Therapy is required to establish the effectiveness of Morita Therapy for a UK population. However, a number of methodological, procedural and clinical uncertainties associated with such a trial first require addressing.

Methods/Design

The Morita Trial is a mixed methods study addressing the uncertainties associated with an evaluation of Morita Therapy compared with treatment as usual for depression and anxiety. We will undertake a pilot randomised controlled trial with embedded qualitative study. Sixty participants with major depressive disorder, with or without anxiety disorders, will be recruited predominantly from General Practice record searches and randomised to receive Morita Therapy plus treatment as usual or treatment as usual alone. Morita Therapy will be delivered by accredited psychological therapists. We will collect quantitative data on depressive symptoms, general anxiety, attitudes and quality of life at baseline and four month follow-up to inform future sample size calculations; and rates of recruitment, retention and treatment adherence to assess feasibility. We will undertake qualitative interviews in parallel with the trial, to explore people’s views of Morita Therapy. We will conduct separate and integrated analyses on the quantitative and qualitative data.

Discussion

The outcomes of this study will prepare the ground for the design and conduct of a fully-powered evaluation of Morita Therapy plus treatment as usual versus treatment as usual alone, or inform a conclusion that such a trial is not feasible and/or appropriate. We will obtain a more comprehensive understanding of these issues than would be possible from either a quantitative or qualitative approach alone.

Trial registration

Current Controlled Trials ISRCTN17544090 registered on 23 July 2015.
Appendix
Available only for authorised users
Literature
1.
Andrews G, Sanderson K, Slade T, Issakidis C. Why does the burden of disease persist? Relating the burden of anxiety and depression to effectiveness of treatment. Bull World Health Organ. 2000;78:446–54.PubMedPubMedCentral
2.
3.
Layard R. The depression report: A new deal for depression and anxiety disorders, (No. 15). Centre for Economic Performance, LSE; 2006.
4.
Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJ, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013;10(11):e1001547.CrossRefPubMedPubMedCentral
5.
Andrews G, Henderson S, Hall W. Prevalence, comorbidity, disability and service utilisation Overview of the Australian National Mental Health Survey. Br J Psychiatry. 2001;178:145–53.CrossRefPubMed
6.
Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). Jama. 2003;289:3095–105.CrossRefPubMed
7.
O'Brien M, Singleton N, Bumpstead R, Office For National Statistics LSSD. Psychiatric morbidity among adults living in private households, 2000. London (United Kingdom): The Stationery Office; 2001.
8.
Keller MB. Long-term treatment of recurrent and chronic depression. J Clin Psychiatry. 2001;62:3–5.CrossRefPubMed
9.
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602.CrossRefPubMed
10.
National Institute for Health and Clinical Excellence. Depression: Management of depression in primary and secondary care, National Institute for Health and Clinical Excellence; 2009.
11.
National Collaborating Centre for Mental Health. Generalised Anxiety Disorder in Adults: Management in Primary, Secondary and Community Care, Leicester and London, The British Psychological Society and the Royal College of Psychiatrists (NICE Clinical Guidelines, No. 113); 2011.
12.
Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA, et al. Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials. 2004;25:119–42.CrossRefPubMed
13.
14.
Clark DM, Layard R, Smithies R, Richards DA, Suckling R, Wright B. Improving access to psychological therapy: Initial evaluation of two UK demonstration sites. Behav Res Ther. 2009;47:910–20.CrossRefPubMedPubMedCentral
15.
Hollon SD, Munoz RF, Barlow DH, Beardslee WR, Bell CC, Bernal G, et al. Psychosocial intervention development for the prevention and treatment of depression: promoting innovation and inreasing access. Biol Psychiatry. 2002;52:610–30.CrossRefPubMed
16.
Morita M, Kondō A, LeVine P. Morita Therapy and the True Nature of Anxiety-Based Disorders. Albany: State University of New York Press; 1998.
17.
Nakamura K, Kitanishi K, Maruyama S, Ishiyama FI, Ito K, Tatematsu K, et al. Guidelines for practising outpatient morita therapy. Tokyo: Japanese Society for Morita Therapy; 2010.
18.
Ogawa B. Desire For Life: The Practitioner’s Introduction to Morita Therapy for the Treatment of Anxiety Disorders. Indiana: XLibris Publ; 2013.
19.
Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. Br Med J. 2008;337:a1655.CrossRef
20.
21.
Richards DA, Hill JJ, Gask L, Lovell K, Chew-Graham C, Bower P, et al. Clinical effectiveness of collaborative care for depression in UK primary care (CADET): cluster randomised controlled trial. Br Med J. 2013;347:f4913.CrossRef
22.
Wiles N, Thomas L, Abel A, Ridgway N, Turner N, Campbell J, et al. Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial. Lancet. 2013;381:375–84.CrossRefPubMed
23.
Rhodes S, Richards DA, Ekers D, McMillan D, Byford S, Farrand PA, et al. Cost and outcome of behavioural activation versus cognitive behaviour therapy for depression (COBRA): study protocol for a randomised controlled trial. Trials. 2014;15:29.CrossRefPubMedPubMedCentral
24.
Creswell JW, Plano Clark VL. Designing and conducting mixed methods research. 2nd ed. Thousan Oaks: Sage Publications, Inc.; 2011.
25.
Borglin G. The value of mixed methods for researching complex interventions. In: Richards DA, Hallberg IR, editors. Complex Interventions in Health: An overview of research methods. Oxon: Routledge; 2015. p. 29–45.
26.
Browne RH. On the use of a pilot sample for sample size determination. Stat Med. 1995;14:1933–40.CrossRefPubMed
27.
Borson S, Scanlan J, Brush M, Vitaliano P, Dokmak A. The Mini-Cog: a cognitive ‘vital signs’ measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry. 2000;15:1021–7.CrossRefPubMed
28.
Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression. J Gen Intern Med. 1996;12:439–45.CrossRef
29.
First MB, Williams JBW, Spitzer RL, Gibbon M. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Clinical Trials Version (SCID-CT). New York: Biometrics Research, New York State Psychiatric Institute; 2007.
30.
31.
32.
33.
LeVine P. Morita‐Based Therapy and Its Use Across Cultures in the Treatment of Bulimia Nervosa. J Counsel Dev. 1993;72(1):82–90.CrossRef
34.
LeVine P. Classic Morita Therapy: Consciousness, Nature and Trauma, State University of New York Press, USA. (In Press)
35.
Ogawa B. A River to Live By: The 12 Life Principles of Morita Therapy. Philadelphia: Xlibris/Random House; 2007.
36.
Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092–7.CrossRefPubMed
37.
Ware JE, Kosinski M, Dewey JE, Gandek B. SF-36 health survey: manual and interpretation guide. Lincoln: Quality Metric Inc; 2000.
38.
Mundt JC, Marks IM, Shear MK, Greist JM. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002;180:461–4.CrossRefPubMed
39.
Richards DA, Mullan EG, Ishiyama FI, Nakamura K. Developing an Outcome Framework for Measuring the Impact of Morita Therapy: A Report from a Consensus Development Process. J Morita Ther. 2011;22:165–73.
40.
Taylor M. Interviewing. In: Holloway I, editor. Qualitative Research in Health Care. Maidenhead: Open University Press; 2011. p. 29–55.
41.
Hill JJ, Kuyken W, Richards DA. Developing stepped care treatment for depression (STEPS): study protocol for a pilot randomised controlled trial. Trials. 2014;15:452.CrossRefPubMedPubMedCentral
42.
43.
Lancaster GA. Pilot and feasibility studies come of age! Pilot Feasibility Stud. 2015;1(1):1.CrossRef
44.
45.
Ritchie J, Spencer L, O’Connor W. Qualitative research practice: A guide for social science students and researchers. London: Sage; 2003.
46.
Thorne S. Data analysis in qualitative research. Evid Based Nurs. 2000;3:68–70.CrossRef
47.
Miles MB, Huberman AM. Qualitative data analysis: An expanded sourcebook. London: Sage; 1994.
48.
Dingwall R, Murphy E, Watson P, Greatbatch D, Parker S. Catching goldfish: quality in qualitative research. J Health Serv Res Policy. 1998;3(3):167–72.PubMed
49.
O’Cathain A, Hoddinott P, Lewin S, Thomas KJ, Young B, et al. Maximising the impact of qualitative research in feasibility studies for randomised controlled trials: guidance for researchers. Pilot Feasibility Stud. 2015;1:32.CrossRef
50.
World Medical Association. World Medical Association Declaration of Helsinki. Ethical principles for edical research involving human subjects. Bull World Health Organ. 2001;79:373.
51.
52.
Department of Health. Mental Capacity Act. London: HMSO; 2005.
53.
54.
55.
The National Institute for Health Research Evaluation Trials and Studies Coordinating Centre (NETSCC) glossary: The National Institute for Health Research Evaluation Trials and Studies Coordinating Centre (NETSCC) Q8 glossary. http://​www.​netscc.​ac.​uk/​glossary/​. Accessed 25 Sep 2015.
56.
Arain M, Campbell MJ, Cooper CL, Lancaster GA. What is a pilot or feasibility study? A review of current practice and editorial policy. BMC Med Res Methodol. 2010;10:67.CrossRefPubMedPubMedCentral
57.
O’Cathain A, Murphy E, Nicholl J. The quality of mixed methods studies in health services research. J Health Serv Res Policy. 2008;13:92–8.CrossRefPubMed
58.
O’Cathain A, Thomas KJ, Drabble SJ, Rudolph A, Hewison J. What can qualitative research do for randomised controlled trials? A systematic mapping review. British Medical Journal Open. 2013, 3. doi: 10.​1136/​bmjopen-2013-002889
Metadata
Title
Morita therapy for depression and anxiety (Morita Trial): study protocol for a pilot randomised controlled trial
Authors
Holly Victoria Rose Sugg
David A. Richards
Julia Frost
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Trials / Issue 1/2016
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-016-1279-3

Other articles of this Issue 1/2016

Trials 1/2016 Go to the issue

Study protocol

GLP-1 analogues for neuroprotection after out-of-hospital cardiac arrest: study protocol for a randomized controlled trial

Study protocol

Improving GHB withdrawal with baclofen: study protocol for a feasibility study for a randomised controlled trial

Study protocol

COmmunity-based Rehabilitation after Knee Arthroplasty (CORKA): study protocol for a randomised controlled trial

Study protocol

Effects of the pattern of glucocorticoid replacement on neural processing, emotional reactivity and well-being in healthy male individuals: study protocol for a randomised controlled trial

Study protocol

Sequential learning of psychomotor and visuospatial skills for laparoscopic suturing and knot tying – study protocol for a randomized controlled trial “The shoebox study”

Study protocol

Temperature-controlled laminar airflow in severe asthma for exacerbation reduction (The LASER Trial): study protocol for a randomised controlled trial